Cargando…
Gliotoxicity of the cyanotoxin, β-methyl-amino-(L)-alanine (BMAA)
The amino acid variant β-methyl-amino-(L)-alanine (BMAA) has long been associated with the increased incidence and progression of the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC). Previous studies have indicated that BMAA damages neurons via excitotoxic mechanisms. We have c...
Autores principales: | Chiu, Alexander S., Gehringer, Michelle M., Braidy, Nady, Guillemin, Gilles J., Welch, Jeffrey H., Neilan, Brett A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601369/ https://www.ncbi.nlm.nih.gov/pubmed/23508043 http://dx.doi.org/10.1038/srep01482 |
Ejemplares similares
-
Does α-Amino-β-methylaminopropionic Acid (BMAA) Play a Role in Neurodegeneration?
por: Chiu, Alexander S., et al.
Publicado: (2011) -
Quantitative proteomics analysis of zebrafish exposed to sub-lethal dosages of β-methyl-amino-L-alanine (BMAA)
por: Frøyset, Ann Kristin, et al.
Publicado: (2016) -
Non-Proteinogenic Amino Acid β-N-Methylamino-L-Alanine (BMAA): Bioactivity and Ecological Significance
por: Koksharova, Olga A., et al.
Publicado: (2022) -
β-methylamino-L-alanine (BMAA) is not found in the brains of patients with confirmed Alzheimer’s disease
por: Meneely, Julie P., et al.
Publicado: (2016) -
Simultaneous Analysis of Cyanotoxins β-N-methylamino-L-alanine (BMAA) and Microcystins-RR, -LR, and -YR Using Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS)
por: Pravadali-Cekic, Sercan, et al.
Publicado: (2023)